Notable News to Focus: Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stock observed trading -35.33% off 52-week high price. On the other end, the stock has been noted 14.80% away from low price over the last 52-weeks. The stock disclosed a move of -20.78% away from 50 day moving average and -25.25% away from 200 day moving average. Moving closer, we can see that shares have been trading -5.91% off 20-day moving average. It has market cap of $5.82B.

On March 31, 2020, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) provided an update regarding the impact of COVID-19 on its business and the actions it is taking to mitigate the spread of this virus.

Jazz provides essential medicines to patients around the world and we are committed to delivering on this important mission.  We have implemented a robust continuity plan to address the impact of COVID-19 on our business.  We are highly focused on ensuring patients have access to our medicines and protecting the health and safety of our employees and the communities in which we operate, said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals.  The company is in a strong financial position, having entered the year with over $1 billion in cash and investments and access to significant additional liquidity.  Our financial strength prepares us to navigate through this pandemic while continuing to execute on our key strategic objectives to support our long-term growth.

Jazz sees a limited financial impact, given its portfolio of differentiated products addressing chronic and life-threatening diseases. However, given the global economic slowdown, reduced field-based interactions with healthcare professionals and the uncertainty surrounding the scale and duration of the pandemic, the company, at this time, cannot rule out future impact on its business and associated guidance.  Jazz expects to provide an update on all key business areas during its first quarter 2020 financial results in early May.

The Ireland based company Jazz Pharmaceuticals plc moved with change of 0.14% to $99.74 with the total traded volume of 709472 shares in recent session versus to an average volume of 679.93K shares. The stock was observed in the 5 days activity at 4.31%. The one month performance of stock was -20.28%. JAZZ’s shares are at -32.90% for the quarter and driving a -30.22% return over the course of the past year and is now at -33.19% since this point in 2018.  Right now the stock beta is 1.29. The average volatility for the week and month was at 5.29% and 8.23% respectively. There are 58.32M shares outstanding and 54.56M shares are floated in market.